Organization

Bristol-Myers Squibb

0 members · 1 reader this month

What's driving coverage of Bristol-Myers Squibb right now?

Corporate ratings

High Risk

Bristol-Myers Squibb was rated High Risk because it scored poorly across cancellations, discriminatory philanthropy, and employment protection, indicating a pattern of race- and identity-based policies over merit-based practices. The company also showed high risk in advocacy bias, funding, and political actions, suggesting its governance is heavily influenced by partisan and activist priorities rather than core business objectives.

CancellationsHigh Risk
Discriminatory PhilanthropyHigh Risk
Employment ProtectionHigh Risk
Advocacy BiasHigh Risk
FundingHigh Risk
Political ActionsHigh Risk

coverage spread: L24/C38/R38

Comments

Ask Genius by OpenServe:

Free account · your comment posts right after signup

Bristol-Myers Squibb

0 members · 1 reader this month

What's driving coverage of Bristol-Myers Squibb right now?

Corporate ratings

High Risk

Bristol-Myers Squibb was rated High Risk because it scored poorly across cancellations, discriminatory philanthropy, and employment protection, indicating a pattern of race- and identity-based policies over merit-based practices. The company also showed high risk in advocacy bias, funding, and political actions, suggesting its governance is heavily influenced by partisan and activist priorities rather than core business objectives.

CancellationsHigh Risk
Discriminatory PhilanthropyHigh Risk
Employment ProtectionHigh Risk
Advocacy BiasHigh Risk
FundingHigh Risk
Political ActionsHigh Risk

coverage spread: L24/C38/R38

Comments

Ask Genius by OpenServe:

Free account · your comment posts right after signup

Board Bias

View Full Board Bias Report available; leadership political contributions show Republican Support $180,751 and Democratic Support $173,336.

Assessment by 1792 Exchange. Summary generated by IJR from their published rating.

34 sources

Business

BMS to Build $2.3B Houston Campus; Lilly Expands

Bristol Myers Squibb is investing about $2.3 billion to build a 600,000-square-foot modular, multi-modal manufacturing campus at Generation Park in Houston, part of its $40 billion five-year U.S. investment plan, to produce small molecules, biologics, and antibody-drug conjugates while enabling future expansion. The project will create roughly 500 permanent jobs and about 2,000 construction roles through 2030, supported by Texas incentives, as drugmakers continue expanding domestic manufacturing under government pressure to boost U.S. production.

32 sources

Bristol-Myers Squibb across IJR

Ask Genius by OpenServe about Bristol-Myers Squibb Create in Studio Build a game Watch videos

The Bristol-Myers Squibb Company, doing business as Bristol Myers Squibb (BMS), is an American multinational pharmaceutical company. Headquartered in Princeton, New Jersey, BMS is one of the world's largest pharmaceutical companies and consistently ranks on the Fortune 500 list of the largest U.S. corporations. For fiscal 2022, it had a total revenue of $46.2 billion.

Overview

The Bristol-Myers Squibb Company, doing business as Bristol Myers Squibb (BMS), is an American multinational pharmaceutical company. Headquartered in Princeton, New Jersey, BMS is one of the world's largest pharmaceutical companies and consistently ranks on the Fortune 500 list of the largest U.S. corporations. For fiscal 2022, it had a total revenue of $46.2 billion. Bristol Myers Squibb manufactures prescription pharmaceuticals and biologics in several therapeutic areas, including cancer, HIV/AIDS, cardiovascular disease, diabetes, hepatitis, rheumatoid arthritis, and psychiatric disorders. BMS's primary research and development (R&D) sites are located in Lawrence, New Jersey (formerly Squibb, near Princeton), Summit, New Jersey, formerly HQ of Celgene, New Brunswick, New Jersey, Redwood City, California, and Seville in Spain, with other sites in Devens and Cambridge, Massachusetts, Braine-l'Alleud, Belgium, Tokyo, Japan, Bangalore, India, and Wirral, United Kingdom. BMS previously had an R&D site in Wallingford, Connecticut (formerly Bristol-Myers). History

From Wikipedia (CC BY-SA 4.0).

Bristol-Myers Squibb across IJR

Ask Genius by OpenServe about Bristol-Myers Squibb Create in Studio Build a game Watch videos

Bristol-Myers Squibb

Corporate ratings

Comments

Bristol Myers exits Cellares deal, capacity doubt

Cullen Capital Expands Stakes Across AXTA, CLX

Bristol-Myers Squibb

Corporate ratings

Comments

Bristol Myers exits Cellares deal, capacity doubt

Cullen Capital Expands Stakes Across AXTA, CLX

Overview

BMS to Build $2.3B Houston Campus; Lilly Expands

Bristol-Myers Squibb across IJR

Overview

Bristol-Myers Squibb across IJR